127 related articles for article (PubMed ID: 38637094)
1. Inflammatory breast cancer: Epidemiologic data and therapeutic results.
Boussen H; Berrazaga Y; Sherif Kullab ; Manai M; Berrada N; Mejri N; Siala I; Levine PH; Cristofanilli M
Int Rev Cell Mol Biol; 2024; 384():1-23. PubMed ID: 38637094
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory breast cancer in Tunisia: epidemiological and clinical trends.
Boussen H; Bouzaiene H; Ben Hassouna J; Dhiab T; Khomsi F; Benna F; Gamoudi A; Mourali N; Hechiche M; Rahal K; Levine PH
Cancer; 2010 Jun; 116(11 Suppl):2730-5. PubMed ID: 20503401
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco.
Soliman AS; Kleer CG; Mrad K; Karkouri M; Omar S; Khaled HM; Benider AL; Ayed FB; Eissa SS; Eissa MS; McSpadden EJ; Lo AC; Toy K; Kantor ED; Xiao Q; Hampton C; Merajver SD
Breast Dis; 2011-2012; 33(4):159-69. PubMed ID: 23001584
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for inflammatory and non-inflammatory breast cancer in North Africa.
Schairer C; Hablas A; Eldein IAS; Gaafar R; Rais H; Mezlini A; Ayed FB; Ayoub WB; Benider A; Tahri A; Khouchani M; Aboulazm D; Karkouri M; Eissa S; Bastawisy AE; Yehia M; Gadalla SM; Swain SM; Merajver SD; Brown LM; Pfeiffer RM; Soliman AS
Breast Cancer Res Treat; 2020 Nov; 184(2):543-558. PubMed ID: 32876910
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
Schairer C; Hablas A; Eldein IAS; Gaafar R; Rais H; Mezlini A; Ayed FB; Ayoub WB; Benider A; Tahri A; Khouchani M; Aboulazm D; Karkouri M; Eissa S; Pfeiffer RM; Gadalla SM; Swain SM; Merajver SD; Brown LM; Soliman AS
Breast Cancer Res Treat; 2019 Jul; 176(2):407-417. PubMed ID: 31006821
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.
Masuda H; Brewer TM; Liu DD; Iwamoto T; Shen Y; Hsu L; Willey JS; Gonzalez-Angulo AM; Chavez-MacGregor M; Fouad TM; Woodward WA; Reuben JM; Valero V; Alvarez RH; Hortobagyi GN; Ueno NT
Ann Oncol; 2014 Feb; 25(2):384-91. PubMed ID: 24351399
[TBL] [Abstract][Full Text] [Related]
7. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory breast cancer in Tunisia from 2005 to 2010: epidemiologic and anatomoclinical transitions from published data.
Mejri N; Boussen H; Labidi S; Bouzaiene H; Afrit M; Benna F; Rahal K
Asian Pac J Cancer Prev; 2015; 16(3):1277-80. PubMed ID: 25735367
[TBL] [Abstract][Full Text] [Related]
9. Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).
Slaoui M; Zoure AA; Mouh FZ; Bensouda Y; El Mzibri M; Bakri Y; Amrani M
BMC Cancer; 2018 Jul; 18(1):713. PubMed ID: 29976157
[TBL] [Abstract][Full Text] [Related]
10. Implementation of a Multidisciplinary Inflammatory Breast Cancer Program for Quality Improvement.
Hussain MM; Ashley G; Daniel S; Sachin J; Amy K; Doreen A; Sasha B; Roman S; Ko Un P
Clin Breast Cancer; 2023 Aug; 23(6):e354-e358. PubMed ID: 37301712
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
Lacerda L; Reddy JP; Liu D; Larson R; Li L; Masuda H; Brewer T; Debeb BG; Xu W; Hortobágyi GN; Buchholz TA; Ueno NT; Woodward WA
Stem Cells Transl Med; 2014 Jul; 3(7):849-56. PubMed ID: 24833589
[TBL] [Abstract][Full Text] [Related]
12. Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.
Chaher N; Arias-Pulido H; Terki N; Qualls C; Bouzid K; Verschraegen C; Wallace AM; Royce M
Breast Cancer Res Treat; 2012 Jan; 131(2):437-44. PubMed ID: 21360074
[TBL] [Abstract][Full Text] [Related]
13. MARCKS protein overexpression in inflammatory breast cancer.
Manai M; Thomassin-Piana J; Gamoudi A; Finetti P; Lopez M; Eghozzi R; Ayadi S; Lamine OB; Manai M; Rahal K; Charafe-Jauffret E; Jacquemier J; Viens P; Birnbaum D; Boussen H; Chaffanet M; Bertucci F
Oncotarget; 2017 Jan; 8(4):6246-6257. PubMed ID: 28009981
[TBL] [Abstract][Full Text] [Related]
14. Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia.
Schairer C; Soliman AS; Omar S; Khaled H; Eissa S; Ayed FB; Khalafallah S; Ayoub WB; Kantor ED; Merajver S; Swain SM; Gail M; Brown LM
Cancer Med; 2013 Apr; 2(2):178-84. PubMed ID: 23634285
[TBL] [Abstract][Full Text] [Related]
15. Development of CNS metastases and survival in patients with inflammatory breast cancer.
Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory breast cancer: a single centre analysis.
Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK; Sharma DN
Asian Pac J Cancer Prev; 2014; 15(7):3207-10. PubMed ID: 24815472
[TBL] [Abstract][Full Text] [Related]
17. Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.
Tsai CJ; Li J; Gonzalez-Angulo AM; Allen PK; Woodward WA; Ueno NT; Lucci A; Krishnamurthy S; Gong Y; Yang W; Cristofanilli M; Valero V; Buchholz TA
Am J Clin Oncol; 2015 Jun; 38(3):242-7. PubMed ID: 23648437
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.
Liu J; Chen K; Jiang W; Mao K; Li S; Kim MJ; Liu Q; Jacobs LK
J Cancer Res Clin Oncol; 2017 Jan; 143(1):161-168. PubMed ID: 27704268
[TBL] [Abstract][Full Text] [Related]
19. Features of breast cancer in developing countries, examples from North-Africa.
Corbex M; Bouzbid S; Boffetta P
Eur J Cancer; 2014 Jul; 50(10):1808-1818. PubMed ID: 24767469
[TBL] [Abstract][Full Text] [Related]
20. A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.
Hirko KA; Soliman AS; Banerjee M; Ruterbusch J; Harford JB; Merajver SD; Schwartz K
Breast J; 2014; 20(2):185-91. PubMed ID: 24372839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
